Document is current
Any future updates will be listed below
-
Authors
Westergaard, David
Lundgaard, Agnete Troen
Vomstein, Kilian
Fich, Line
Hviid, Kathrine Vauvert Römmelmayer
Egerup, Pia
Christiansen, Ann-Marie Hellerung
Nielsen, Josefine Reinhardt
Lindman, Johanna
Holm, Peter Christoffer
Hartwig, Tanja Schlaikjær
Jørgensen, Finn Stener
Zedeler, Anne
Kolte, Astrid Marie
Westh, Henrik
Jørgensen, Henrik Løvendahl
la Cour Freiesleben, Nina
Banasik, Karina
Brunak, Søren
Nielsen, Henriette Svarre
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 25 November 2024
First Online: 18 December 2024
Declarations
:
: The PREGCO study was approved by the Knowledge Centre for Data Protection and Compliance, the Capital Region of Denmark (P-2020–255), and by the Scientific Ethics Committee of the Capital Region of Denmark (journal number H-20022647). All PREGCO participants provided written informed consent.Danish legislation allows for register-based research to be conducted without the consent of participants and without ethical committee approval. Registry data, i.e., the Danish Medical Birth Registry, was held at Statistics Denmark, which is the Danish national statistical institution.
: Not applicable.
: SB has ownerships in Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S, and managing board memberships in Proscion A/S. HSN received personal payment or honoraria for lectures and presentations from Ferring Pharmaceuticals, Merck, Astra Zeneca, Cook Medical, and Ibsa Nordic.
